Bones, neoplasm, malignant, primary or secondary
The VA rates Bones, neoplasm, malignant, primary or secondary under Diagnostic Code 5012 at a single 100% level. At 100%, veterans receive $3939/month or more in compensation.
Rating schedule — DC 5012 at a glance
- Minimum rating
- 100%
- Maximum rating
- 100%
- Rating tiers
- 1
- CFR section
- § 4.71a
- Body system
- Musculoskeletal System
- Secondary conditions
- 0
Lowest schedular rating available
Full schedular disability
100%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Bones, neoplasm, malignant, primary or secondary?
| Rating | Criteria |
|---|---|
| 100% | Bones, neoplasm, malignant, primary or secondary |
“Bones, neoplasm, malignant, primary or secondary”
Common Questions About Bones, neoplasm, malignant, primary or secondary VA Ratings
What is the VA rating range for Bones, neoplasm, malignant, primary or secondary?
The VA rates Bones, neoplasm, malignant, primary or secondary under Diagnostic Code 5012 at 100%. The minimum 100% rating requires: Bones, neoplasm, malignant, primary or secondary. The maximum 100% rating requires: Bones, neoplasm, malignant, primary or secondary.
Which 38 CFR diagnostic code does the VA use for Bones, neoplasm, malignant, primary or secondary?
The VA rates Bones, neoplasm, malignant, primary or secondary under Diagnostic Code (DC) 5012, governed by 38 CFR 38 CFR § 4.71a. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can Bones, neoplasm, malignant, primary or secondary qualify for TDIU?
Yes — a 100% rating for Bones, neoplasm, malignant, primary or secondary alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.
What evidence supports a higher rating for Bones, neoplasm, malignant, primary or secondary?
The key evidence for Bones, neoplasm, malignant, primary or secondary is documentation of how the condition affects daily functioning. For musculoskeletal conditions, range of motion measurements (active, passive, weight-bearing, and non-weight-bearing per Correia v. McDonald) and flare-up documentation are critical. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for Bones, neoplasm, malignant, primary or secondary?
The C&P examiner uses a Musculoskeletal System DBQ and evaluates your condition against the DC 5012 rating criteria. Expect range of motion testing in multiple positions. Under Correia v. McDonald, the examiner must test active, passive, weight-bearing, and non-weight-bearing range of motion. Report your worst flare-up symptoms — if you cannot attend during a flare, request the exam be rescheduled.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits